Gender differences in health-related quality of life measured by the Sarcoidosis Health Questionnaire

被引:0
作者
Łukasz Gwadera
Adam J. Białas
Witold Górski
Mikołaj A. Iwański
Joanna Miłkowska-Dymanowska
Paweł Górski
Wojciech J. Piotrowski
机构
[1] Medical University of Lodz,Department of Pneumology and Allergy, World Association for Sarcoidosis and Other Granulomatous Disorders (WASOG) Recognized Sarcoidosis Clinic
[2] Medical University of Lodz,Department of Pathobiology of Respiratory Diseases
来源
Scientific Reports | / 11卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Sarcoidosis is granulomatous disease, which complex etiology is yet to be fully discovered. In the majority of cases its course is self-limiting. However it can have different clinical manifestations and can be debilitating condition with great impact on health-related quality of life (HRQL). The aim of our study was to assess if there are any differences in HRQL dependent to gender. We examined a group of 33 males and 42 females (with no differences in mean age, disease activity, TLCO, FEV1, FVC, FEV1/FVC) with a use of Sarcoidosis Health Questionnaire. We revealed lower total and daily functioning score in female group. Further analyses stratified by sex and activity of the disease presented many significant differences between the groups, revealing important issues for the discussion about gender specific differences in the HRQL of patients with sarcoidosis. In spite of clinical presentation may be similar, expectations and main concerns of sarcoidosis patient can vary between females and males. Therefore, it appears that in terms of education and symptomatic treatment accents should be put differently depending on the gender of the patient. Our results may also point to a need for more gender-oriented patient-physician communication which could enable better understanding, potentially improve adherence to therapy and decrease the risk of possible complications.
引用
收藏
相关论文
共 51 条
[1]  
Detmar SB(1999)Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999 Am. J. Respir. Crit. Care Med. 160 736-755
[2]  
Muller MJ(2002)Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial JAMA 288 3027-3034
[3]  
Schornagel JH(1993)Measuring health-related quality of life Ann. Intern. Med. 118 622-629
[4]  
Wever LDV(1989)Epidemiological study on sarcoidosis in Japan. Recent trends in incidence and prevalence rates and changes in epidemiological features Sarcoidosis 6 138-146
[5]  
Aaronson NK(1986)The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival Am. J. Epidemiol. 123 840-845
[6]  
Guyatt GH(2012)The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States Sarcoidosis Vasc. Diffuse Lung Dis. 20 119-127
[7]  
Feeny DH(2007)Sex-specific manifestations of Löfgren’s syndrome Am. J. Respir. Crit. Care Med. 175 40-44
[8]  
Patrick DL(2003)Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients Respir. Med. 97 978-982
[9]  
Yamaguchi M(2010)Health perception and health care access: sex differences in behaviors and attitudes Am. J. Econ. Sociol. 69 783-801
[10]  
Hosoda Y(2017)The utility of selected questionnaires in the assessment of fatigue, depression and health quality in post-sarcoidosis fatigue syndrome Adv. Respir. Med. 85 313-321